The Research Executive Committee is closely involved with the program planning and evaluation activities of the UPCI. Discussions regarding the scientific activities and growth ofthe scientific programs are on the agenda on a regular basis. Similarly, the services provided by UPCI shared facilities, operational efficiencies and the need for new services are also discussed regularly. A formal presentation ofthe research activities ofthe CCSG programs, developing programs and services provided bythe shared facilities are presented to the Scientific Advisory Council (SAC) members of UPCI at the annual SAC meeting, following which SAC's feedback and recommendations are discussed at the quarterly Program Leaders and Shared Facility Directors meeting to get their input. The Research Executive Committee continues to discuss extensively the recommendations provided by SAC and the subsequent comments by the Program Leaders and Shared Facility Directors to take the appropriate steps to enhance the programs and shared facilities. The Annual Scientific Retreat provides an outstanding opportunity for lab based faculty, medical and hematologic oncologists, residents, clinical fellows, postdoctoral fellows (lab based) and graduate students to meet together and share ideas. The 2-day event also provides the opportunity to hear presentations from newly recruited faculty members as well as from established UPCI members who have innovative and important research findings. Funds are being requested for two aspects of UPCI's program planning and evaluation activities. These are funds for annual meetings of UPCI's Scientific Advisory Committee, and the UPCI Annual Scientific Retreat.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA047904-25
Application #
8519361
Study Section
Special Emphasis Panel (ZCA1-RTRB-L)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
25
Fiscal Year
2013
Total Cost
$121,502
Indirect Cost
$69,737
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Posluszny, Donna M; Dew, Mary Amanda; Beckjord, Ellen et al. (2016) Existential challenges experienced by lymphoma survivors: Results from the 2010 LIVESTRONG Survey. J Health Psychol 21:2357-66
Vyas, Avani R; Moura, Michelle B; Hahm, Eun-Ryeong et al. (2016) Sulforaphane Inhibits c-Myc-Mediated Prostate Cancer Stem-Like Traits. J Cell Biochem 117:2482-95
Pollack, Ian F; Jakacki, Regina I; Butterfield, Lisa H et al. (2016) Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study. J Neurooncol :
Concha-Benavente, Fernando; Srivastava, Raghvendra M; Trivedi, Sumita et al. (2016) Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer. Cancer Res 76:1031-43
Gojo, Ivana; Beumer, Jan H; Pratz, Keith W et al. (2016) A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia. Clin Cancer Res :
Delgado, Evan; Boisen, Michelle M; Laskey, Robin et al. (2016) High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome. Gynecol Oncol 141:348-56
Kirkwood, Caitlin M; MacDonald, Matthew L; Schempf, Tadhg A et al. (2016) Altered Levels of Visinin-Like Protein 1 Correspond to Regional Neuronal Loss in Alzheimer Disease and Frontotemporal Lobar Degeneration. J Neuropathol Exp Neurol 75:175-82
Chen, Mingqing; Sun, Fan; Han, Lei et al. (2016) Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling. Oncotarget 7:33363-73
Whiteside, Theresa L (2016) Tumor-Derived Exosomes and Their Role in Cancer Progression. Adv Clin Chem 74:103-41
Blundon, Malachi A; Schlesinger, Danielle R; Parthasarathy, Amritha et al. (2016) Proteomic analysis reveals APC-dependent post-translational modifications and identifies a novel regulator of β-catenin. Development 143:2629-40

Showing the most recent 10 out of 885 publications